This is a standard executive appointment filling the VP Finance role. No financial guidance or operational changes were provided. Monitor future filings for any updates on the company's financial strategy or capital allocation.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 28 $1.19entry
- T+1 · 6d ago −5.04%α −3.27% · $1.13
- T+5 · due 7h ago Pending
- T+5 · todayOpen
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Gain Therapeutics appointed Jeanette Weidner as Vice President, Finance, effective October 28, 2026, with an annual base salary of $275,000, a target bonus of 35% of base salary, and an option to purchase 130,000 shares. This is a routine officer appointment with standard compensation terms; no departure or material financial impact is disclosed.
Key Facts
- Jeanette Weidner appointed Vice President, Finance, effective October 28, 2026, and will serve as principal financial and accounting officer.
- Annual base salary of $275,000 with a target annual bonus of 35% of base salary.
- Grant of an option to purchase 130,000 shares vesting over four years (25% on first anniversary, remainder monthly).
- Severance: 6 months base salary for termination without Cause or for Good Reason; 12 months base salary plus pro-rata bonus and full equity acceleration upon a Change of Control termination.
- Ms. Weidner has 18 years of experience, most recently as a financial consultant at Senseonics Holdings Inc. (Nasdaq: SENS).
Financial Impact
Annual base salary of $275,000; option for 130,000 shares at fair market value on grant date; target bonus 35% of base salary.
Risk Factors
- No material risks identified from this routine appointment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-119673 |
| Document: tm2627863d1_8k.htm | 0001104659-26-119673 |
| Document: 0001104659-26-119673-index-headers.html | 0001104659-26-119673 |
| Document: 0001104659-26-119673-index.html | 0001104659-26-119673 |
| Document: 0001104659-26-119673.txt | 0001104659-26-119673 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 4d ago | 3 | $1.13 | awaiting T+5 | awaiting T+5 | $1.13 (+0.44%) |
Oct 28, 2026 6d ago | 8-K | $1.19 | awaiting T+5 | awaiting T+5 | $1.13 (−4.62%) |
Oct 1, 2026 4w ago | Press Release | $1.72 $1.62 | ▼ −6.10% | ▼ −7.41% | $1.13 (−34.01%) |
Oct 1, 2026 4w ago | 8-K | $1.72 $1.62 | ▼ −6.10% | ▼ −7.41% | $1.13 (−34.01%) |
Aug 11, 2026 12w ago | Press Release | $2.06 $2.03 | ▼ −1.46% | ▼ −1.05% | $1.13 (−44.90%) |
Jul 16, 2026 15w ago | 8-K | $1.66 $1.82 | ▲ +9.64% | ▲ +11.31% | $1.13 (−31.63%) |
Jun 29, 2026 18w ago | 8-K | $2.03 $1.81 | ▼ −10.84% | ▼ −11.44% | $1.13 (−44.09%) |
Jun 29, 2026 18w ago | Press Release | $2.03 $1.81 | ▼ −10.84% | ▼ −11.44% | $1.13 (−44.09%) |
May 26, 2026 23w ago | 8-K | $1.82 $1.96 | ▲ +7.69% | ▲ +6.61% | $1.13 (−37.64%) |
May 11, 2026 25w ago | Press Release | $1.82 $1.62 | ▼ −10.99% | ▼ −10.90% | $1.13 (−37.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers